文献速递胸部肿瘤支持与姑息治疗

护士主导的简短行为干预改善晚期肺癌患者呼吸困难:随机对照试验

Randomized Controlled Trial of a Nurse-Led Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer.
PubMed 文献 · J Clin Oncol · 2024-08-01

纳入247例至少中度呼吸困难的晚期肺癌患者,随机比较护士主导两次会话干预(呼吸技巧、体位与风扇疗法)与常规护理。第8周时干预组mMRCDS呼吸困难评分改善(差值-0.33,95%CI -0.61至-0.05),CDS不适感亚量表(差值-0.59,95%CI -1.16至-0.01)及FACT-L功能状况(差值1.39,95%CI 0.18至2.59)优于对照组;总体生活质量、心理症状和活动水平无显著差异。

要点

  • 护士主导两次会话行为干预可改善晚期肺癌患者第8周mMRCDS呼吸困难评分(差值-0.33,95%CI -0.61至-0.05)。
  • 干预组CDS不适感亚量表(差值-0.59,95%CI -1.16至-0.01)和FACT-L功能状况(差值1.39,95%CI 0.18至2.59)优于对照组。
  • 两组总体生活质量、心理症状和24周内活动水平无显著差异。

核心结论

  • 对晚期肺癌患者,可扩展的行为干预减轻了难以治疗的呼吸困难症状。
  • 需要进一步研究如何增强干预的长期效果及拓展至其他结局。

研究设计与样本

  • 随机对照试验,纳入247例报告至少中度呼吸困难的晚期肺癌患者,比较护士主导两次会话干预(聚焦呼吸技巧、体位和风扇疗法)与常规护理。
  • 在基线及第8周(主要终点)、16周和24周完成呼吸困难(mMRCDS、CDS)、生活质量(FACT-L)、心理症状(医院焦虑抑郁量表)和活动水平(Godin-Shephard休闲时间体力活动问卷)测量。
  • 采用协方差分析和纵向混合效应模型检验干预效果。

主要发现

  • 样本平均年龄66.15岁,女性占55.9%,主要为晚期非小细胞肺癌(85.4%)。
  • 与常规护理相比,干预组第8周mMRCDS患者报告呼吸困难改善(差值-0.33,95%CI -0.61至-0.05),但CDS总分无差异。
  • 干预组CDS不适感亚量表呼吸困难较对照组减轻(差值-0.59,95%CI -1.16至-0.01),FACT-L功能状况较对照组更好(差值1.39,95%CI 0.18至2.59)。
  • 两组第8周及24周纵向总体生活质量、心理症状和活动水平无显著差异。

关键数值与推荐

  • 主要终点为第8周mMRCDS呼吸困难评分,干预组与对照组差值-0.33(95%CI -0.61至-0.05)。
  • CDS不适感亚量表差值-0.59(95%CI -1.16至-0.01),FACT-L功能状况差值1.39(95%CI 0.18至2.59)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究如何增强干预的长期效果及拓展至其他结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In patients with lung cancer, dyspnea is one of the most prevalent and disabling symptoms, for which effective treatments are lacking. We examined the efficacy of a nurse-led brief behavioral intervention to improve dyspnea in patients with advanced lung cancer. METHODS: Patients with advanced lung cancer reporting at least moderate breathlessness (n = 247) were enrolled in a randomized trial of a nurse-led two-session intervention (focused on breathing techniques, postural positions, and fan therapy) versus usual care. At baseline and weeks 8 (primary end point), 16, and 24, participants completed measures of dyspnea (Modified Medical Research Council Dyspnea Scale [mMRCDS]; Cancer Dyspnoea Scale [CDS]), quality of life (Functional Assessment of Cancer Therapy-Lung [FACT-L]), psychological symptoms (Hospital Anxiety and Depression Scale), and activity level (Godin-Shephard Leisure Time Physical Activity Questionnaire). To examine intervention effects, we conducted analysis of covariance and longitudinal mixed effects models. RESULTS: The sample (Agemean = 66.15 years; 55.9% female) primarily included patients with advanced non-small cell lung cancer (85.4%). Compared with usual care, the intervention improved the primary outcome of patient-reported dyspnea on the mMRCDS (difference = -0.33 [95% CI, -0.61 to -0.05]) but not the CDS total score at 8 weeks. Intervention patients also reported less dyspnea on the CDS sense of discomfort subscale (difference = -0.59 [95% CI, -1.16 to -0.01]) and better functional well-being per the FACT-L (difference = 1.39 [95% CI, 0.18 to 2.59]) versus the control group. Study groups did not differ in overall quality of life, psychological symptoms, or activity level at 8 weeks or longitudinally over 24 weeks. CONCLUSION: For patients with advanced lung cancer, a scalable behavioral intervention alleviated the intractable symptom of dyspnea. Further research is needed on ways to enhance intervention effects over the long-term and across additional outcomes.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Greer JA, Post KE, Chabria R, et al. Randomized Controlled Trial of a Nurse-Led Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer. J Clin Oncol. 2024. PMID: 39088766. doi:10.1200/JCO.24.00048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。